Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Porwit

Showing results (111-120 of 119) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 119 results.
British Journal of Haematology|May 26, 2010
Maintenance treatment with azacytidine for patients with high-risk myelodysplastic syndromes (MDS) or acute myeloid leukaemia following MDS in complete remission after induction chemotherapyMichael Grövdal, Mohsen Karimi, Rasheed Khan, et al.
European Journal of Haematology|June 22, 2010
Childhood near-tetraploid acute lymphoblastic leukemia: an EGIL study on 36 casesPetr Lemez, Andishe Attarbaschi, Marie C Béné, et al.
Cytometry. Part B, Clinical Cytometry|November 23, 2022
Multicenter prospective evaluation of diagnostic potential of flow cytometric aberrancies in myelodysplastic syndromes by the ELN iMDS flow working groupWolfgang Kern, Theresia M Westers, Frauke Bellos, et al.
Haematologica|October 21, 2016
Immunophenotypic analysis of erythroid dysplasia in myelodysplastic syndromes. A report from the IMDSFlow working groupTheresia M Westers, Eline M P Cremers, Uta Oelschlaegel, et al.
Cytometry. Part B, Clinical Cytometry|December 13, 2021
Clinical application of flow cytometry in patients with unexplained cytopenia and suspected myelodysplastic syndrome: A report of the European LeukemiaNet International MDS-Flow Cytometry Working GroupArjan A van de Loosdrecht, Wolfgang Kern, Anna Porwit, et al.
Cytometry. Part B, Clinical Cytometry|December 11, 2021
Flow cytometric analysis of myelodysplasia: Pre-analytical and technical issues-Recommendations from the European LeukemiaNetVincent H J van der Velden, Frank Preijers, Ulrika Johansson, et al.
Cytometry. Part B, Clinical Cytometry|December 20, 2022
Multiparameter flow cytometry in the evaluation of myelodysplasia: Analytical issues: Recommendations from the European LeukemiaNet/International Myelodysplastic Syndrome Flow Cytometry Working GroupAnna Porwit, Marie C Béné, Carolien Duetz, et al.
Haematologica|June 24, 2009
Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromesArjan A van de Loosdrecht, Canan Alhan, Marie Christine Béné, et al.
Leukemia & Lymphoma|August 25, 2012
Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes: position paper of an International Consortium and the European LeukemiaNet Working GroupArjan A van de Loosdrecht, Robin Ireland, Wolfgang Kern, et al.
Pageof 12

Showing results (111-120 of 119) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 119 results.
British Journal of Haematology|May 26, 2010
Maintenance treatment with azacytidine for patients with high-risk myelodysplastic syndromes (MDS) or acute myeloid leukaemia following MDS in complete remission after induction chemotherapyMichael Grövdal, Mohsen Karimi, Rasheed Khan, et al.
European Journal of Haematology|June 22, 2010
Childhood near-tetraploid acute lymphoblastic leukemia: an EGIL study on 36 casesPetr Lemez, Andishe Attarbaschi, Marie C Béné, et al.
Cytometry. Part B, Clinical Cytometry|November 23, 2022
Multicenter prospective evaluation of diagnostic potential of flow cytometric aberrancies in myelodysplastic syndromes by the ELN iMDS flow working groupWolfgang Kern, Theresia M Westers, Frauke Bellos, et al.
Haematologica|October 21, 2016
Immunophenotypic analysis of erythroid dysplasia in myelodysplastic syndromes. A report from the IMDSFlow working groupTheresia M Westers, Eline M P Cremers, Uta Oelschlaegel, et al.
Cytometry. Part B, Clinical Cytometry|December 13, 2021
Clinical application of flow cytometry in patients with unexplained cytopenia and suspected myelodysplastic syndrome: A report of the European LeukemiaNet International MDS-Flow Cytometry Working GroupArjan A van de Loosdrecht, Wolfgang Kern, Anna Porwit, et al.
Cytometry. Part B, Clinical Cytometry|December 11, 2021
Flow cytometric analysis of myelodysplasia: Pre-analytical and technical issues-Recommendations from the European LeukemiaNetVincent H J van der Velden, Frank Preijers, Ulrika Johansson, et al.
Cytometry. Part B, Clinical Cytometry|December 20, 2022
Multiparameter flow cytometry in the evaluation of myelodysplasia: Analytical issues: Recommendations from the European LeukemiaNet/International Myelodysplastic Syndrome Flow Cytometry Working GroupAnna Porwit, Marie C Béné, Carolien Duetz, et al.
Haematologica|June 24, 2009
Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromesArjan A van de Loosdrecht, Canan Alhan, Marie Christine Béné, et al.
Leukemia & Lymphoma|August 25, 2012
Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes: position paper of an International Consortium and the European LeukemiaNet Working GroupArjan A van de Loosdrecht, Robin Ireland, Wolfgang Kern, et al.
Pageof 12